Published on 01 Oct 2021

HTA appoints Dr Colin Sullivan as new CEO

    The Human Tissue Authority (HTA) is delighted to announce that Dr Colin Sullivan will join the HTA as its Chief Executive, replacing Allan Marriott-Smith who is leaving at the end of October. 

    Colin, currently Chief Operating Officer at the Food Standards Agency, will take up the post on 1 January 2022.

    Chair of the HTA, Lynne Berry CBE, said,

    These are demanding times for the health and care sector, for innovation in the life sciences and for maintaining public trust and professional confidence as we learn from the pandemic experience. We’re very much looking forward to Colin joining us to lead the HTA as we navigate this landscape.

    ‘Colin’s background in scientific research, his experience as a regulator and as a senior civil servant will be invaluable, as will his experience of collaborating with other regulators and stakeholders. Our role as a trusted regulator and thought leader in the regulation of innovation and the life sciences has never been more vital and we’re looking forward to welcoming Colin as our new Chief Executive.

    Colin commented,

    I am delighted to be joining the Human Tissue Authority. As an organisation that attracts high levels of public trust, I am honoured to take up the role of HTA Chief Executive and to play my part in driving forward its mission of ensuring human tissue is used safely and ethically and with proper consent.

    Colin added,

    I look forward to getting to know the talented team at the HTA as well as working with colleagues from across the health service, government, industry and academia. Britain is a global player in life sciences with many new and innovative treatments. I want the HTA to continue to play its part in regulating and facilitating these cutting-edge developments in a safe and ethical manner.

    Notes to editors 

    About the HTA

    The HTA was established in 2005, and is an Executive Non-Departmental Public Body, more commonly referred to as an “Arms-Length Body” (ALB), sponsored by the Department of Health and Social Care. 

    What the HTA does

    We regulate organisations that remove, store and use human tissue for research, medical treatment, post-mortem examination, education and training, and display in public. We also give approval for organ and bone marrow donations from living people.

    We separate our approach to regulating and licensing establishments into 6 distinct sectors: 

    1. Anatomy 
    2. Human Application 
    3. Organ Donation and Transplantation (living and deceased) 
    4. Post Mortem 
    5. Public Display 
    6. Research 

    More information about the HTA can be found on our website.

    Media contact
    Shirley Dent,, 020 7269 1958